Bladder preserving combined modality therapy for invasive bladder cancer.
The purpose of this paper is to increase the nurse's knowledge about invasive bladder cancer through discussion of a current protocol treatment using chemo and radiation therapy. Pathophysiology, clinical features, and current medical management are addressed along with appropriate nursing interventions, including symptom management and patient/family education. Research supports the observation that once patients complete the protocol regimen, the complete response rate is high and the need for radical surgery is low.
Held
J
J
Albert Einstein Medical Center, Philadelphia, PA.
Volpe
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D002985:Clinical Protocols / Q000592:standards; D003131:Combined Modality Therapy / Q000592:standards; D015653:Cystectomy / Q000592:standards; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D009367:Neoplasm Staging; D010347:Patient Care Planning; D011878:Radiotherapy / Q000592:standards; D001749:Urinary Bladder Neoplasms / Q000451:nursing / Q000473:pathology / Q000628:therapy*; D014747:Vinblastine / Q000008:administration & dosage
D014747:Vinblastine; D002945:Cisplatin; D008727:Methotrexate